Great Novel Therapeutics Biotech & Medicals Corp
TPEX:7427
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Great Novel Therapeutics Biotech & Medicals Corp
TPEX:7427
|
TW |
|
M
|
Madison Pacific Properties Inc
TSX:MPC
|
CA |
|
A
|
Alumina Ltd
F:WMC1
|
AU |
|
E
|
eGalax_eMPIA Technology Inc
TPEX:3556
|
TW |
|
Movano Inc
NASDAQ:MOVE
|
US |
|
GCX Metals Ltd
ASX:GCX
|
US |
|
S
|
Starcore International Mines Ltd
F:V4JA
|
CA |
|
International Tower Hill Mines Ltd
TSX:ITH
|
CA |
|
P
|
PGI Energy Inc
OTC:PGIE
|
US |
|
S
|
Skygate Solutions Bhd
KLSE:SKYGATE
|
MY |
|
K
|
Komipharm International Co Ltd
KOSDAQ:041960
|
KR |
|
S
|
Superlon Holdings Bhd
KLSE:SUPERLN
|
MY |
|
C
|
Credit Acceptance Corp
F:2D5
|
US |
|
Madoro Metals Corp
XTSX:MDM
|
CA |
|
Gaz PAO
MOEX:GAZAP
|
RU |
|
X
|
XOX Technology Bhd
KLSE:XOXTECH
|
MY |
|
K
|
Kingsview Minerals Ltd
F:0L4
|
CA |
|
A
|
AsicLand Co Ltd
KOSDAQ:445090
|
KR |
|
TNS Energo Mariy El PAO
MOEX:MISBP
|
RU |
|
I
|
Issara Real Estate Investment Trust
SET:ISSARA
|
TH |
|
Vanadium Resources Ltd
ASX:VR8
|
AU |
|
Sun Max Tech Ltd
TWSE:6591
|
TW |
|
F
|
Finetek Co Ltd
KOSDAQ:131760
|
KR |
|
H
|
Hydrogen Freehold and Leasehold Real Estate Investment Trust
SET:HYDROGEN
|
TH |
Shareholder Yield
Current shareholder yield for Great Novel Therapeutics Biotech & Medicals Corp is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Great Novel Therapeutics Biotech & Medicals Corp
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -46% |
| Market Capitalization | 3.9B TWD |
| Shares Outstanding | 53 710 000 |
| Percentage of Shares Shorted |
N/A
|
